Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Hisao, Mori"'
Autor:
Ryo, Naito, Katsumi, Miyauchi, Satoshi, Yasuda, Koichi, Kaikita, Masaharu, Akao, Junya, Ako, Tetsuya, Matoba, Masato, Nakamura, Nobuhisa, Hagiwara, Kazuo, Kimura, Atsushi, Hirayama, Kunihiko, Matsui, Hisao, Ogawa, Hisao, Mori
Publikováno v:
JAMA cardiology. 7(8)
Appropriate regimens of antithrombotic therapy for patients with atrial fibrillation (AF) and coronary artery disease (CAD) have not yet been established.To compare the total number of thrombotic and/or bleeding events between rivaroxaban monotherapy
Autor:
Shohei, Yuasa, Hareaki, Yamamoto, Yoshiro, Suzuki, Keiichi, Chin, Hiroshi, Ukai, Yusuke, Kobayashi, Yuichiro, Yano, Hisao, Mori
Publikováno v:
Blood Pressure Monitoring. 27:314-319
The relationship between the white-coat effect (WCE), defined as white-coat hypertension under treatment, and the frequency of orthostatic hypotension (OH) is not known. We conducted an orthostatic test in patients with WCE to determine the frequency
Autor:
Yumi Ikehara, Kazuomi Kario, Sadayoshi Ito, Takayoshi Ohkubo, Hisao Mori, Tomohiro Katsuya, Takuya Tsuchihashi, Hiromi Rakugi, Kei Asayama, Shinichiro Ueda, Yusuke Ohya, Satoshi Umemura, Katsuyuki Miura, Masaaki Miyakawa
Publikováno v:
Journal of Hypertension
OBJECTIVE: The aim was to compare short-term and long-term reproducibilities of in-office unattended blood pressure (BP), namely automated office blood pressure (AOBP), conventionally measured attended office BP, and self-measured home BP. METHODS: A
Autor:
Masahiro Sugawara, Yoshihiko Saito, Takahiro Hayashi, Kenichi Tsujita, Shinya Hiramitsu, Masako Waki, Yutaka Wakasa, Naoto Yokota, Naoki Kawai, Hisao Mori, Hideaki Jinnouchi, Ichiro Hisatome, Kunihiko Matsui, Hisao Ogawa, Kazuo Kimura, Yusuke Ohya, Kazuaki Uchiyama, Sunao Kojima, Febuxostat for Cerebral, Hirokazu Kakuda, Cardiorenovascular Events Prevention Study (Freed) investigators, Eiichi Tokutake
Publikováno v:
Rheumatology. 61:2346-2359
Objectives Hyperuricaemia is recognized as an independent risk marker for cardiovascular and renal diseases. However, uric acid is a powerful free-radical scavenger, and the optimal level of serum uric acid (SUA) determining outcomes is unknown. This
Autor:
Sunao Kojima, Kazuaki Uchiyama, Naoto Yokota, Eiichi Tokutake, Yutaka Wakasa, Shinya Hiramitsu, Masako Waki, Hideaki Jinnouchi, Hirokazu Kakuda, Takahiro Hayashi, Naoki Kawai, Masahiro Sugawara, Hisao Mori, Kenichi Tsujita, Kunihiko Matsui, Ichiro Hisatome, Yusuke Ohya, Kazuo Kimura, Yoshihiko Saito, Hisao Ogawa
Publikováno v:
Cardiovascular drugs and therapyReferences.
Purpose: Inflammation plays an important role in the initiation and progression of atherosclerosis, leading to poor clinical outcomes. Hyperuricemia is associated with the activation of the Nod-like receptor protein 3 inflammasome. Here, we investiga
Autor:
Keiko, Arai, Tetsuo, Nishikawa, Yoko, Matsuzawa, Shigeyuki, Ohtsu, Shin-Ichiro, Shirabe, Shohei, Yuasa, Koichi, Hirao, Hisao, Mori
Publikováno v:
Diabetes therapy : research, treatment and education of diabetes and related disorders. 13(2)
Periodontal disease is a common inflammation worldwide and is not only the foremost cause of tooth loss but also a cause of deterioration of glycemic control in patients with diabetes mellitus. In addition, effective glycemic management improves the
Autor:
Koich Hirao, Shohei Yuasa, Tetsuo Nishikawa, Keiko Arai, Shin-ichiro Shirabe, Hisao Mori, Yoko Matsuzawa, Shigeyuki Ohtsu
Publikováno v:
Diabetol Int
AIM: We aimed to investigate the certainty of using sulfonylureas in Japanese patients with type 2 diabetes mellitus (T2DM) by analyzing data from the 2018 Nationwide Survey on Actual Intervention for T2DM by Japanese Practitioners (NSAID Study). MET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2852822d37db4f126d2f117b98ad6807
https://europepmc.org/articles/PMC8733091/
https://europepmc.org/articles/PMC8733091/
Autor:
Ichiro Hisatome, Naoki Kawai, Yoshihiko Saito, Kunihiko Matsui, Hisao Ogawa, Hisao Mori, Kazuo Kimura, Masahiro Sugawara, Eiichi Tokutake, Yutaka Wakasa, Hirokazu Kakuda, Shinya Hiramitsu, Hideaki Jinnouchi, Sunao Kojima, Masako Waki, Yusuke Ohya, Kazuaki Uchiyama, Naoto Yokota, Takahiro Hayashi
Publikováno v:
European Heart Journal. 40:1778-1786
Aims To compare the occurrence of cerebral, cardiovascular, and renal events in patients with hyperuricaemia treated with febuxostat and those treated with conventional therapy with lifestyle modification. Methods and results This multicentre, prospe
Autor:
Cardiorenovascular Events Prevention Study (Freed) investigators, Yoshihiko Saito, Hideaki Jinnouchi, Naoto Yokota, Eiichi Tokutake, Hisao Mori, Yusuke Ohya, Kazuaki Uchiyama, Masaaki Konishi, Hisao Ogawa, Masahiro Sugawara, Kazuo Kimura, Kenichi Tsujita, Masako Waki, Shinya Hiramitsu, Takahiro Hayashi, Yutaka Wakasa, Sunao Kojima, Kunihiko Matsui, Ichiro Hisatome, Naoki Kawai, Hirokazu Kakuda
Publikováno v:
SSRN Electronic Journal.
We previously reported on the FREED study, which found that febuxostat reduced the risk of adverse clinical outcome in patients with asymptomatic hyperuricemia without gout. We have now investigated outcomes in subgroups of FREED patients with and wi
Autor:
Shigeyuki Ohtsu, Shin-ichiro Shirabe, Koich Hirao, Tetsuo Nishikawa, Yoko Matsuzawa, Hisao Mori, Keiko Arai, Shohei Yuasa
Publikováno v:
Diabetes Therapy
Introduction Considering the increase in the number of patients with diabetes, the quality of diabetes care provided by general practitioners (GP) is critical for preventing complications. We performed a nationwide survey to determine whether the dia